Tomomi Tenjin Selected Research

blonanserin

1/2017	Retraction: 'Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia'.
12/2014	Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial.
4/2013	[Blonanserin in the treatment of schizophrenia].
1/2013	Profile of blonanserin for the treatment of schizophrenia.
1/2012	Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomomi Tenjin Research Topics

Disease

7	Schizophrenia (Dementia Praecox) 01/2017 - 01/2011

Drug/Important Bio-Agent (IBA)

7	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 01/2011
5	blonanserinIBA 01/2017 - 01/2012
2	Risperidone (Risperdal Consta)FDA LinkGeneric 04/2013 - 01/2013
2	Haloperidol (Haldol)FDA LinkGeneric 04/2013 - 01/2013
1	BenzodiazepinesIBA 03/2012
1	Pharmaceutical PreparationsIBA 01/2011
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2011
1	Biperiden (Akineton)FDA Link 01/2011

Therapy/Procedure

1	Therapeutics 01/2013